Clinical Trials Directory

Trials / Completed

CompletedNCT01085071

Comparison of Two Potassium Targets Within the Normal Range in Intensive Care Patients

GRIP-COMPASS Trial: Computer-driven Glucose and Potassium Regulation Program in Intensive Care Patients With COMparison of PotASSium Targets Within normokAlemic Range

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
1,225 (actual)
Sponsor
University Medical Center Groningen · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Rationale: It is well known that distinctly abnormal blood potassium values can cause serious complications such as cardiac arrhythmias. Although potassium regulation is generally considered important, hardly any research has been done about potassium regulation in intensive care patients. The investigators hypothesize that different potassium target-values, within the as normal accepted range, may have different effects in critically ill patients. Study design: A prospective trial comparing two different potassium target-values. Potassium will be tightly regulated with the already fully operational GRIP-II computer program. Study population: 1200 adult patients admitted at the thoracic intensive care unit of the University Medical Center Groningen. Intervention: Comparison between two variations of standard therapy: potassium target-value of 4.0 mmol/L versus 4.5 mmol/L. Main study parameters/endpoints: The primary endpoint is the incidence of atrial fibrillation or atrial flutter from ICU-admission to hospital discharge. Secondary endpoints are serum levels of potassium and the other main electrolytes, renal function and renal potassium excretion, the relation with insulin and glucose, the cumulative fluid balance, (ICU) length of stay and mortality.

Conditions

Interventions

TypeNameDescription
DRUGPotassium ChlorideKCl is continuously administered and titrated towards a Normal-high Potassium (4.5 mmol/L)
DRUGPotassium ChlorideKCl is continuously administered and titrated towards a Normal-low Potassium (4.0 mmol/L)

Timeline

Start date
2009-06-01
Primary completion
2011-12-01
Completion
2012-01-01
First posted
2010-03-11
Last updated
2013-01-21

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01085071. Inclusion in this directory is not an endorsement.